iVRS

iVRS News

Successfully Completed 100 + Extractable and Leachable (E & L) Studies.

Extractable & Leachable Studies conducted at iVRS has been approved by USFDA and Health Canada.

In Vitro Release Test (IVRT) Studies conducted at iVRS has been accepted by Saudi Food and Drug Authority (SFDA).

Successfully completed PK based bioequivalence study of Cladribine in RRMS Patients for Jordan Food and Drug Administration (JFDA) submission.

Rich Experience in Handling Global Biosimilar Studies.

Successfully Completed Global Ophthalmology Device Study.

Our Process and Systems are ISO 9001 & ISO 27001 Compliant.

iVRS-Logo_resized-187x300 (3)

T. Vijay Bhaskar

Sr. Director - Clinical Development

Vijay leads our strong Clinical Development team. With over 20 years in healthcare industry and 17+ years’ in core clinical research domain, Vijay has managed studies in multiple therapies including oncology, infection, respiratory, cardiovascular, endocrinology and ophthalmology across different geographical regions.
The effective leadership attribute in him has been influential in striking the right chord with national and international Sponsors. His responsibilities include directing the clinical development, sponsor contracting, execution of budgetary negotiations, ensuring clinical, operational and medical governance excellence across all clinical domain programs at iVRS.

Subsribe To Our Newsletter

Stay in touch with us to get latest news and special offers.

Location

Bangalore, India

Call Us

+91 80 45500700

Email Us

info@ivrs.org.in